γ-Secretase cleavage of the Alzheimer risk factorTREM2 is determined by its intrinsic structural dynamics.
EMBO J. 39:e104247 (2020)
Sequence variants of the microglial expressedTREM2 (triggering receptor expressed on myeloid cells 2) are a major risk factor for late onset Alzheimer's disease.TREM2 requires a stable interaction withDAP12 in the membrane to initiate signaling, which is terminated byTREM2 ectodomain shedding and subsequent intramembrane cleavage by gamma-secretase. To understand the structural basis for the specificity of the intramembrane cleavage event, we determined the solution structure of theTREM2 transmembrane helix (TMH). Caused by the presence of a charged amino acid in the membrane region, theTREM2-TMHadopts a kinked structure with increased flexibility. Charge removal leads toTMHstabilization and reduced dynamics, similar to its structure in complex withDAP12. Strikingly, these dynamical features match with the site of the initial gamma-secretase cleavage event. These data suggest an unprecedented cleavage mechanism by gamma-secretase where flexibleTMHregions act as key determinants of substrate cleavage specificity.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publication type
Article: Journal article
Document type
Scientific Article
Thesis type
Editors
Keywords
Dynamics ; Intramembrane Protease ; Nmr ; Structure ; Trem2; Amyloid Precursor Protein; Magnetic-resonance Relaxation; Myeloid Cells-2 Trem2; Model-free Approach; Transmembrane Helix; Backbone Dynamics; Membrane-proteins; Domain; Site; Macromolecules
Keywords plus
Language
english
Publication Year
2020
Prepublished in Year
HGF-reported in Year
2020
ISSN (print) / ISBN
0261-4189
e-ISSN
1460-2075
ISBN
Book Volume Title
Conference Title
Conference Date
Conference Location
Proceedings Title
Quellenangaben
Volume: 39,
Issue: 20,
Pages: ,
Article Number: e104247
Supplement: ,
Series
Publisher
Wiley
Publishing Place
Heidelberg, Germany
Day of Oral Examination
0000-00-00
Advisor
Referee
Examiner
Topic
University
University place
Faculty
Publication date
0000-00-00
Application date
0000-00-00
Patent owner
Further owners
Application country
Patent priority
Reviewing status
Peer reviewed
POF-Topic(s)
30505 - New Technologies for Biomedical Discoveries
30203 - Molecular Targets and Therapies
Research field(s)
Enabling and Novel Technologies
PSP Element(s)
G-553600-001
G-503000-001
Grants
Projekt DEAL
Gauss Centre for Supercomputing e.V.
German Research Foundation (DFG)
TUM Institute for Advanced Study - German Excellence Initiative
Copyright
Erfassungsdatum
2020-10-20